Cellectis S.A.
ALCLS.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €41,506 | €755 | €19,171 | €73,949 |
| % Growth | 5,397.5% | -96.1% | -74.1% | – |
| Cost of Goods Sold | €9,182 | €737 | €1,772 | €36,275 |
| Gross Profit | €41,506 | €18 | €17,399 | €37,674 |
| % Margin | 100% | 2.4% | 90.8% | 50.9% |
| R&D Expenses | €90,536 | €87,646 | €97,501 | €86,950 |
| G&A Expenses | €17,602 | €16,812 | €17,494 | €37,869 |
| SG&A Expenses | €17,602 | €14,801 | €17,494 | €44,201 |
| Sales & Mktg Exp. | €0 | -€2,011 | €0 | €6,332 |
| Other Operating Expenses | -€7,078 | -€5,127 | -€7,930 | -€8,040 |
| Operating Expenses | €101,060 | €97,320 | €107,065 | €123,111 |
| Operating Income | -€59,554 | -€97,302 | -€89,666 | -€85,437 |
| % Margin | -143.5% | -12,887.7% | -467.7% | -115.5% |
| Other Income/Exp. Net | €22,793 | -€19,162 | -€8,935 | €5,998 |
| Pre-Tax Income | -€36,761 | -€116,464 | -€98,601 | -€97,483 |
| Tax Expense | €0 | €371 | €87 | -€11,203 |
| Net Income | -€36,761 | -€101,059 | -€98,688 | -€86,280 |
| % Margin | -88.6% | -13,385.3% | -514.8% | -116.7% |
| EPS | -0.41 | -2.08 | -2.17 | -1.93 |
| % Growth | 80.3% | 4.1% | -12.4% | – |
| EPS Diluted | -0.41 | -1.92 | -2.17 | -1.93 |
| Weighted Avg Shares Out | 89,852 | 52,641 | 45,547 | 44,771 |
| Weighted Avg Shares Out Dil | 89,852 | 57,013 | 45,547 | 44,820 |
| Supplemental Information | – | – | – | – |
| Interest Income | €11,278 | €2,495 | €1,066 | €608 |
| Interest Expense | €7,453 | €5,307 | €15,541 | €3,695 |
| Depreciation & Amortization | €19,846 | €18,523 | €18,435 | €14,156 |
| EBITDA | -€9,462 | -€92,636 | -€76,378 | -€85,437 |
| % Margin | -22.8% | -12,269.7% | -398.4% | -115.5% |